GlobalData on MSN

NAMSA acquires Labcorp’s medical device testing assets

The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.

NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp

NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has ...
PE Hub

Archimed-backed Namsa picks up Labcorp’s early development medical testing biz

Namsa, which is backed by Archimed, has acquired Labcorp’s US-based early development medical testing business. No financial ...